To test the pathophysiological relevance of our findings, we turned our attention to human PDX leukemia specimens, which were derived from patients with B-precursor acute lymphoblastic leukemia treated with asparaginase-intensive combination chemotherapy on contemporary clinical trials (Figure 7H; Table S3). The gene discussed is ASPG; the disease is leukemia.